Gelesis Holdings, Inc. (GLSHQ)
USD 0.0
(-79.0%)
USD 0.0
(-79.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -121.8 Million USD | -43.35% |
| 2021 | -84.97 Million USD | 0.0% |
| 2020 | - USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -9.99 Million USD | 16.53% |
| 2023 Q1 | -11.97 Million USD | 54.72% |
| 2022 FY | -121.8 Million USD | -43.35% |
| 2022 Q4 | -26.44 Million USD | -47.5% |
| 2022 Q3 | -17.92 Million USD | 47.81% |
| 2022 Q2 | -34.35 Million USD | 20.26% |
| 2022 Q1 | -43.08 Million USD | -113.98% |
| 2021 Q1 | -16.6 Million USD | 0.0% |
| 2021 Q3 | -28.27 Million USD | -41.7% |
| 2021 Q2 | -19.95 Million USD | -20.2% |
| 2021 FY | -84.97 Million USD | 0.0% |
| 2021 Q4 | -20.13 Million USD | 28.8% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -9021.1% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -2314.638% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -582.501% |
| Nascent Biotech, Inc. | -2.22 Million USD | -5362.449% |
| Rebus Holdings, Inc. | -664 Thousand USD | -18244.277% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 248.813% |
| Qrons Inc. | -643.67 Thousand USD | -18823.466% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -31166.781% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -119.439% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -29217.005% |
| Skye Bioscience, Inc. | -13.67 Million USD | -790.929% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -69.679% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 2578.346% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -46439.511% |
| SQZ Biotechnologies Company | -75.82 Million USD | -60.641% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -4173.135% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -7829.825% |
| Mesoblast Limited | -84.14 Million USD | -44.754% |
| Marizyme, Inc. | -34.08 Million USD | -257.344% |
| Genus plc | 6.4 Million USD | 2003.219% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 1350.259% |
| Pharming Group N.V. | -4.87 Million USD | -2396.258% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -6031.754% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -12978.013% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -1358.754% |
| ContraFect Corporation | -56.88 Million USD | -114.112% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -2574.277% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -8588.073% |
| IMV Inc. | -38.67 Million USD | -214.976% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -4327.958% |
| MultiCell Technologies, Inc. | -722.81 USD | -16851631.437% |
| ONE Bio Corp. | 13.68 Million USD | 990.294% |
| Accustem Sciences Inc. | -3.74 Million USD | -3151.265% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -106.486% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -25115.397% |
| Q BioMed Inc. | -3.44 Million USD | -3435.101% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 3540.847% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -4535.775% |
| Biomind Labs Inc. | -1 Million USD | -11964.742% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -121.577% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -4098.397% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -1732.216% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -6433.36% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -406570.673% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -667.536% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -6202.668% |
| GB Sciences, Inc. | -1.42 Million USD | -8474.814% |
| Alpha Cognition Inc. | -9.7 Million USD | -1155.007% |
| HST Global, Inc. | -140.9 Thousand USD | -86344.25% |
| CSL Limited | 3.7 Billion USD | 103.29% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -10728.105% |
| Halberd Corporation | -75.05 Thousand USD | -162199.8% |
| Enzolytics Inc. | -2.14 Million USD | -5568.559% |
| Agentix Corp. | -1.37 Million USD | -8779.568% |
| Resverlogix Corp. | -12.74 Million USD | -855.416% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -3744.554% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 71.343% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -11567.241% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -4072.233% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -7612.389% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -3477.291% |
| AVAX Technologies, Inc. | 6.69 Million USD | 1919.934% |
| Zenith Capital Corp. | -8.94 Million USD | -1262.026% |
| Genscript Biotech Corporation | -415.79 Million USD | 70.705% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -699090.632% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -4860.907% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -70919.956% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -5975.849% |
| Kadimastem Ltd | -3.04 Million USD | -3906.447% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -12277.992% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -9597.93% |
| BioStem Technologies, Inc. | -7.77 Million USD | -1465.837% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -67016.291% |
| LadRx Corporation | -3.82 Million USD | -3085.615% |
| Cell Source, Inc. | -4.32 Million USD | -2716.098% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -17631.422% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -17631.422% |
| NovAccess Global Inc. | -2.46 Million USD | -4837.894% |
| Affymax, Inc. | -15.04 Million USD | -709.557% |
| Itoco Inc. | -919.14 Thousand USD | -13152.171% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -2773.858% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -10785.255% |
| Mobile Lads Corp. | -554.55 Thousand USD | -21864.836% |
| CytoDyn Inc. | -18.05 Million USD | -574.527% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -483833.254% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -55246.741% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -21469.159% |
| SYBLEU INC | -149.18 Thousand USD | -81550.355% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -6606.197% |
| International Stem Cell Corporation | -663 Thousand USD | -18271.946% |
| Bioxytran, Inc. | -3.82 Million USD | -3088.516% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -231294.377% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -598749.558% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -235.868% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -7428.183% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -16453.439% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -3815.333% |
| Neutra Corp. | -229.48 Thousand USD | -52977.748% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -594.487% |
| PureTech Health plc | -146.19 Million USD | 16.685% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -466.774% |
| IXICO plc | -1.43 Million USD | -8376.409% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -1183.384% |
| CSL Limited | 3.81 Billion USD | 103.195% |
| Cellectis S.A. | -108.85 Million USD | -11.895% |